Managing and Monitoring Infections and Neurological Toxicities in Patients Receiving Bispecific Therapies

Opinion
Video

Dr. Mohan discusses with Nurse Goff and Nurse Brigle the prevention and management of infections and neurological toxicities in patients receiving bispecific therapies, with a particular focus on the unique considerations of talquetamab targeting GPRC5D.

Video content above is prompted by the following:

  • How do you approach the prevention and management of infections in patients receiving bispecific therapies, particularly considering the unique target of talquetamab (GPRC5D)?
  • What are your protocols for monitoring and managing neurological toxicities in patients receiving bispecific therapies?
    • Are there any specific considerations for talquetamab?

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
Image of a woman wearing a patterned shirt in front of a dark blue background
Photo of a woman wearing a blazer in front of an Oncology Nursing News backdrop
3 experts in this video
3 experts in this video
Photo of a white man with curly hair and in front of a blue Oncology Nursing News backdrop
Related Content